Category Archives: Jamjoom Pharma News

Jamjoom Pharma and Mubadala Bio’s Bioventure Healthcare Partner to Expand Patient Access to Ustekinumab in the UAE

Jamjoom Pharma and Mubadala Bio’s Bioventure Healthcare Partner to Expand Patient Access to Ustekinumab in the UAE Jamjoom Pharma will be the exclusive commercial arm for Bioventure Healthcare’s (BVH) Ustekinumab, combining BVH’s product and supply with Jamjoom Pharma’s outreach, scale and medical education expertise. UAE, October 22, 2026 – Jamjoom Pharma, a regional healthcare player…

Jamjoom Pharma Deepens Decades-Long Ophthalmology Leadership with Exclusive Nordic Pharma Partnership Across MEA

Jamjoom Pharma Deepens Decades-Long Ophthalmology Leadership with Exclusive Nordic Pharma Partnership Across MEA Agreement that brings next-generation Dry Eye Disease treatment Lacrifill to the patients across MENA The Kingdom of Saudi Arabia, 13th September 2026 – Jamjoom Pharma, a pioneer in ophthalmology in the Middle East and Africa for decades and one of the region’s…

Jamjom E-book Development Brief

Jamjom E-book Development Brief We are looking to create an interactive digital e-book inspired by the following reference: https://examples.flippingbook.com/one-stop-shop/6/   Objective: Develop a visually engaging, easy-to-navigate e-book with a flipbook experience that enhances user interaction and presentation.   Key Requirements: Editable Format: The e-book should be built in a way that allows easy future edits…

Jamjoom Pharma Signs Agreement to Acquire Pharmaceutical Manufacturing Facility in Saudi Arabia from Pfizer

Jamjoom Pharma Signs Agreement to Acquire Pharmaceutical Manufacturing Facility in Saudi Arabia from Pfizer Jeddah, Kingdom of Saudi Arabia – [April 27th, 2026] – Jamjoom Pharma, a leading pharmaceutical company in the Middle East and Africa (MEA), today announced the signing of a Facility Sale and Purchase Agreement with Pfizer Saudi Limited Company to acquire…

Jamjoom Pharma’s Financial Results in Q1/2026

Jamjoom Pharma’s Financial Results in Q1/2026 1Q 2026 Financial Summary SAR (mn) 1Q 2026 1Q 2025 YOY Δ% Revenue 481.4 457.5 +5%  Gross profit 310.4 292.8 +6%  Operating profit 172.4 158.2 +9%  Net profit 168.2 157.0 +7%  EBITDA 186.7 172.4 +8%  FCF 180.5 156.6 +15%  EPS 2.4 2.2 +7%    JEDDAH, 23rd April 2026 –…

Manufacturing agreement announced between Jamjoom Pharma and Viatris Arabia Limited LLC

Manufacturing agreement announced between Jamjoom Pharma and Viatris Arabia Limited LLC Saudi Arabia – [22-04-2026] – Jamjoom Pharma, a leading Saudi pharmaceutical healthcare company in the Middle East and Africa (MEA), and Viatris Arabia Limited “LLC”, a part of global healthcare company Viatris, announced a local manufacturing agreement by which Jamjoom Pharma will manufacture several…

“Jamjoom Pharma” and “Caritas Egypt” launch a strategic partnership to enhance eye health and support presidential health initiatives

“Jamjoom Pharma” and “Caritas Egypt” launch a strategic partnership to enhance eye health and support presidential health initiatives Cairo, 21 April 2026: Jamjoom Pharma, one of the fastest-growing pharmaceutical companies in Saudi Arabia and across MEA, announced the signing of a memorandum of understanding with Caritas Egypt, aimed at launching a comprehensive national initiative for…

Jamjoom Pharma and Magrabi Health Group Sign an MoU to Enhance Ophthalmology Services in Saudi Arabia

Jamjoom Pharma and Magrabi Health Group Sign an MoU to Enhance Ophthalmology Services in Saudi Arabia Jeddah, March 26, 2026: In a move reflecting their shared commitment to advancing the healthcare sector and elevating the quality of medical services, Jamjoom Pharma, one of the fastest-growing pharmaceutical companies in the Middle East and Africa, announced the…

Jamjoom Pharma Egypt signs cooperation protocol with Research Institute of Ophthalmology

Jamjoom Pharma Egypt signs cooperation protocol with Research Institute of Ophthalmology Dr. Ali Yehia: We are committed to active participation in training programs and transferring practical expertise to keep pace with developments in ophthalmology  Cairo, 26 January 2025: Jamjoom Pharma, a leading pharmaceutical company, and the Research Institute of Ophthalmology have signed a cooperation protocol…

Iraq’s Ministry of Health and Jamjoom Pharma Sign a Cooperation Protocol to launch ‘Ishraqa’ Glaucoma Awareness Campaign

Iraq’s Ministry of Health and Jamjoom Pharma Sign a Cooperation Protocol to launch ‘Ishraqa’ Glaucoma Awareness Campaign Baghdad, Iraq, October 29, 2025 – In a significant step towards advancing public health and preventive eye care in Iraq, the Iraqi Ministry of Health and Jamjoom Pharma have signed a cooperation protocol to launch the national campaign…